Amendments

Section 809 of the Defense Production Act of 1950 (50 U.S.C. 4589) is amended— (1) in paragraph (10)(A), by adding at the end the following: (vi) Biotechnology, meaning the research, development, manufacturing, or commercialization of— (I) pharmaceutical products (which has the meaning given the term drug in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1))); (II) biological products (as such term is defined in section 351(i) of the Public Health Service Act (42 U.S.C. 262(i))); and (III) therapeutic compounds, including drug discovery platforms, clinical research and development capabilities, biologics manufacturing, and intellectual property and know-how relating to therapeutic compounds,; (2) in paragraph (7)(A), by adding at the end the following: (vi) Biotechnology, meaning the research, development, manufacturing, or commercialization of— (I) pharmaceutical products (which has the meaning given the term drug in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1))); (II) biological products (as such term is defined in section 351(i) of the Public Health Service Act (42 U.S.C. 262(i))); and (III) therapeutic compounds, including drug discovery platforms, clinical research and development capabilities, biologics manufacturing, and intellectual property and know-how relating to therapeutic compounds,; and (3) in paragraph (4)(A), by adding at the end the following: (ix) licensing a prohibited technology from a covered foreign person..